This control plane turns synthetic biotech change-control exports into one review surface: classification rationale, validation evidence, SOP acknowledgment freshness, approval continuity, audit-trail repair, and named cutover readiness before downstream release decisions.
Biotech teams need one board where classification rationale, validation evidence, SOP acknowledgments, approval continuity, audit trails, and cutover readiness stay readable together.
This fits the Kinetic Gain pattern: routing, evidence, approvals, and operator-safe remediation posture for release-critical quality workflows.
The free surface proves the operator model; the commercial path is an embedded change-control board for regulated biotech workflows.